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Total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol,
triglycerides, glucose, insulin, high-sensitivity C-reactive protein, alanine aminotransferase,
aspartate aminotransferase, γ-glutamyltransferase, leptin, adiponectin, tumor necrosis
factor–α, interleukin-6, interleukin-10, fibrinogen, and insulin resistance were assessed in
183 nonsmoking white men aged 35 to 53 years, including 62 who were slim and fit (waist
girth ≤90 cm andmaximal oxygen consumption [VO2max] above average), 24 who were slim
and unfit (waist girth ≤90 cm and VO2max average or below), 39 who were fat and fit (waist
girth ≥100 cmandVO2max above average), and 19whowere fat andunfit (waist girth ≥100 cm
and VO2max average or below). Seventy-six percent gave blood on 2 occasions, and the
average of 1 or 2 blood testswas used in statistical tests.Waist girth (centimeters) and fitness
(milliliters of oxygen per kilogram of fat-free mass) were associated with high-density
lipoprotein cholesterol, leptin, and insulin resistance after adjustment for age, saturated fat
intake, and total energy intake. High-density lipoprotein cholesterol, triglycerides, alanine
aminotransferase, and insulin resistance were significantly different in men who were fat
and fit and those who were fat and unfit. These data suggest that differences in lipid and
lipoprotein concentrations, liver function, and insulin resistance may explain why the risks
of chronic disease are lower in men who are fat and fit than those who are fat and unfit.
© 2011 Elsevier Inc. All rights reserved.1. Introduction
Obesity is associated with increased risk of cardiovascular
disease and type 2 diabetes mellitus [1,2]; however, the risks
of chronic disease are lower in obese men with moderate to
high levels of aerobic fitness [3,4]. Total cholesterol concen-
tration, blood pressure, and other traditional risk factors may
not explain why the risks of chronic disease are lower in menstudy and collected the
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l.2011.06.009who are fat and fit than men who are fat and unfit [3].
Therefore, we assessed traditional [5] and novel [6,7] cardi-
ometabolic risk factors in the present study, including
adipokines [7], markers of inflammation [6-9], and markers
of liver damage [10-12]. We hypothesized that fatness and
fitness would be related to cardiometabolic risk factors, and
we hypothesized that traditional and novel risk factors would
be significantly different in groups of different fatness anddata. O'Donovan, Kearney, and Sherwood analyzed the data. All
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and fitness [13], but the present study was unusually robust.
The within-subject variation in blood-borne cardiometabolic
risk factors is considerable [14], so we took blood on 2
occasions to obtain a better indication of participants'
average levels. The available evidence suggests that fitness
does not reduce all-cause mortality in sedentary men [15], so
we only included active men in the slim and fit group and the
fat and fit group.2. Methods
2.1. Participants
A total of 183 white men took part in this study from January
2006 to July 2007. Health and fitness tests took place at Brunel
University, and most volunteers were recruited from local
employers that e-mailed recruitment literature on our behalf.
Volunteers were also recruited via leaflets at health and
fitness clubs and adverts in health and fitness magazines. We
excluded volunteers aged less than 35 or more than 55 years,
those who had smoked in the last 2 years, those taking
medication that might affect cholesterol or blood pressure,
and those with symptoms of angina or intermittent claudica-
tion [16]. An institutional review board approved this study,
and all participants gave written informed consent.
2.2. Fatness, fitness, and activity
Height and weight were measured with minimal clothing and
without shoes, and body mass index (BMI) was expressed as
kilograms per meter squared. Skinfold thicknesses were
measured at the triceps, biceps, subscapular, and suprailiac
regions; and percentage body fat was estimated [17]. Fat-free
mass (FFM) was estimated as total body weight minus fat
weight. Waist girth was measured with an inelastic tape in a
horizontal plane at the narrowest part of the torso [18]; and
values less than or equal to 90 cm were used to identify slim
men, and values greater than or equal to 100 cm were used to
identify fat men. Aerobic fitness was assessed during an
incremental cycling test, and oxygen consumption was
measured using an automated gas analyzer that was period-
ically validated against the Douglas bag technique (Oxycon
Pro; Viasys Healthcare, Hoechberg, Germany). Exercise tests
were terminated at 80% of age-predicted maximum heart rate
in 25 (14%) of 183 volunteers to reduce the risk of cardiovas-
cular injury [19], and maximal oxygen consumption (VO2max)
was estimated by extrapolating submaximal heart rate and
oxygen uptake values. Maximal oxygen consumption was
expressed in absolute terms (liters per minute) to identify
fitness categories: men who scored “very poor,” “poor,” “fair,”
or “average” were deemed unfit; and men who scored “good,”
“very good,” or “excellent” were deemed fit in relation to age-
specific norms [20]. Fitness categories were derived from
absolute values because heavier individuals are penalized
when VO2max is expressed relative to body weight. The
VO2max was expressed as milliliters of O2 per kilogram FFM
perminute in regressionmodels because FFM is a reflection of
metabolically active tissue. Physical activity was assessedPlease cite this article as: O'Donovan G, et al, Fatness, fitness, a
Metabolism (2011), doi:10.1016/j.metabol.2011.06.009using the Five-City Project Physical Activity Recall Question-
naire [21, 22].
2.3. Cardiometabolic risk factors
Participants were asked to visit the laboratory on 2 occasions
separated by 3 to 10 days to minimize the confounding effect
of biological variation [14]. Participants sat in a chair for at
least 5 minutes at the start of each visit to the laboratory, and
systolic (SBP) and fifth phase diastolic (DBP) blood pressures
were measured twice at the right arm using a mercury
sphygmomanometer. 44 men (24%) gave blood on 1 occasion,
and 139 men (76%) gave blood on 2 occasions; and the average
of 1 or 2 blood tests was used in statistical tests. Venous blood
was drawn in the morning following a 12-hour fast and at
least 24 hours of abstinence from vigorous-intensity activity.
Blood samples were frozen at −80°C before being tested in the
same analyzer run. Total cholesterol concentration, high-
density lipoprotein cholesterol (HDL-C) concentration, low-
density lipoprotein cholesterol (LDL-C) concentration, triglyc-
eride concentration, glucose concentration, insulin concen-
tration, high-sensitivity C-reactive protein (hsCRP)
concentration, alanine aminotransferase (ALT) activity, as-
partate aminotransferase (AST) activity, and γ-glutamyltrans-
ferase (GGT) activity weremeasured using an Abbott Architect
cs8200 analyzer (Abbott Laboratories, Abbott Park, IL). En-
zyme-labeled immunosorbent assay was used to quantify
leptin (DRG Instruments, Marburg, Germany), adiponectin,
tumor necrosis factor (TNF)–α, interleukin (IL)-6, and IL-10 (R &
D Systems, Abingdon, UK). Fibrinogen level was estimated
using the STA-Fib(2) kit and STA-R Evolution analyzer (Stago,
Asnieres, France). The coefficient of variation of each assay
was less than or equal to 5%. Insulin resistance was estimated
from the homeostasis model assessment of insulin resistance
(HOMA), which correlates well with the euglycemic-hyper-
insulinemic clamp technique [23]. Participants were asked to
complete a 7-day food diary, and nutrient intakewas analyzed
using CompEat software (Nutrient Systems, Banbury, UK).
Socioeconomic status was assessed during an interview in
accordance with the Office for National Statistics manual [24].
2.4. Statistical methods
Sample size was determined using the standardized differ-
ence, which is the ratio of the clinically relevant difference
and the standard deviation of the primary outcome variable
[25]. Low-density lipoprotein cholesterol was chosen as the
primary outcome variable, and cross-sectional data suggest
that LDL-C concentration is around 0.8 mmol·L−1 lower in
habitual exercisers than sedentary men [26, 27] and that the
standard deviation in LDL-C concentration is around 0.96
mmol·L−1 [28]. Thus, the standardized difference is 0.8/0.96 =
0.83. When this value is used in Altman's nomogram [25],
there is around a 98% probability at the 5% level of significance
of detecting differences in LDL-C of 0.8 ± 0.96mmol·L−1 with 45
subjects in each group. Because it is difficult to recruit fat and
unfit men [26], we decided to recruit more slim and fit men.
This strategy reduces power compared with a 1:1 ratio, but
gives a 90% probability of detecting a 0.8 ± 0.96-mmol·L−1
difference in LDL-C with 60 slim and fit men (the referencend cardiometabolic risk factors in middle-aged white men,
3M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L X X ( 2 0 1 1 ) X X X – X X Xgroup) and 20men in any other group [25]. Group comparisons
only included unfit men who reported no regular moderate-
intensity (∼4 metabolic equivalents [METs]) or vigorous-
intensity (≥6 METs) activity in the last 2 years and fit men
who reported taking part in at least 60 minutes of vigorous-
intensity aerobic activity per week in the last 2 years, which is
the minimum amount recommended to develop and main-
tain cardiorespiratory fitness (1 MET is equivalent to the
energy expended at rest) [19]. Multiple linear regression was
used to investigate if fatness (waist girth, centimeters) and
fitness (VO2max,milliliters of O2 per kilogram FFMperminute)
were associated with cardiometabolic risk factors. Model 1
contained age and fatness or age and fitness. Model 2
contained age, fatness, and fitness. Model 3 contained age,
fatness, fitness, saturated fat intake, and total energy intake.
Residuals were regarded as normally distributed if results of
Shapiro-Wilk tests were not significant (P > .05); and log10
transformation normalized triglyceride, hsCRP, ALT, and lep-
tin data. General linearmodel analysis of variance was used to
investigate group differences. Hochberg GT2 and Gabriel post
hoc tests were usedwhen sample sizes were different, and the
Games-Howell post hoc test was used when the result of
Levine test of equality of error variance was significant (P < .05)
[29]. All datawere analyzedusing SPSS forWindows, version 15.0
(SPSS, Chicago, IL). All P values presented are 2-tailed.3. Results
Table 1 shows participants' characteristics. The average age
was around 40 years, and around 80% of participants were
employed in managerial and professional occupations. Fat-
ness, fitness, and activity varied widely; and the sample of 183
men included 62 who were slim and fit (waist girth ≤90 cm,
VO2max above average in relation to age-specific norms, and
at least 60 minutes of vigorous-intensity activity per week
in the last 2 years), 24 who were slim and unfit (waist girth
≤90 cm, VO2max average or below, and no regular moderate-
or vigorous-intensity activity in the last 2 years), 39 who were
fat and fit (waist girth ≥100 cm, VO2max above average, andTable 1 – Participants' characteristics (n = 183)
Mean ± SD (range)
Age, y 42 ± 5 (35-53)
Weight, kg 89.9 ± 16.5 (60-141)
BMI, kg·m2 28.1 ± 4.9 (19.1-45.3)
Body fat, % 22 ± 6 (7-33)
Waist girth, cm 93.8 ± 11.7 (67.2-129.0)
Maximal oxygen consumption, L·min−1 3.55 ± 0.71 (1.93-5.49)
Maximal oxygen consumption,
mL O2·kgFFM−1 ·min−1
51.3 ± 9.1 (28.8-79.7)
Years of exercise 14 ± 11 (0-39)
Socioeconomic status
Managerial and professional
occupations, %
79
Intermediate occupations, % 15
Routine and manual occupations, % 5
Other, % 0.5
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the last 2 years), and 19 who were fat and unfit (waist girth
≥100 cm, VO2max average or below, and no regular moderate-
or vigorous-intensity activity in the last 2 years). Waist girth
was not significantly different in men who were slim and fit
and those who were slim and unfit (84 ± 5 and 84 ± 5 cm), but
was higher in men who were fat and fit and those who were
fat and unfit (109 ± 7.5 and 105 ± 6 cm, P < .001 vs slim
groups). Maximal oxygen consumption was not significantly
different in men who were slim and fit and those who were
fat and fit (3.8 ± 0.5 and 4.0 ± 0.5 L·min−1), but was lower in
men who were slim and unfit and those who were fat and
unfit (2.7 ± 0.3 and 2.9 ± 0.7 L·min−1, P < .001 vs fit groups).
Body mass index and body fat were in keeping with group
classifications (Table S1, online supplement).
Cardiometabolic risk factors also varied widely, and the
number of participants who provided at least 1 valid blood
sample ranged from 119 for IL-10 to 183 for glucose (Table S2,
online supplement). Interleukin-10 data were not analyzed
because of the loss of statistical power. SPSS was coded to
ignore other missing values; and the observed power of group
comparisons at the 5% level of significance was 0.31 for
fibrinogen, 0.36 for IL-6, 0.41 for TNF-α, 0.5 for AST, 0.63 for
total cholesterol, and greater than or equal to 0.9 for HDL-C,
LDL-C, triglycerides, glucose, insulin, HOMA, hsCRP, ALT, GGT,
adiponectin, and leptin.
Table 2 shows the relationships between fatness (waist
girth, centimeters), fitness (VO2max, milliliters per kilogram
FFM per minute), and cardiometabolic risk factors. Standard-
ized regression coefficients are not dependent on the units of
measurement and are presented to facilitate interpretation. In
model 1, for example, the standardized regression coefficient
indicates that as waist girth increases by 1 standard deviation,
triglyceride concentration increases by 0.29 standard devia-
tions. The standard deviation for waist girth is 11.7 cm (Table
1), and the standard deviation for triglyceride concentration is
0.66 mmol·L−1 (Table S2, online supplement). Therefore, for
every 11.7-cm increase in waist girth, there is a 0.19-mmol·L−1
increase in triglyceride concentration (0.29 × 0.66 = 0.19).
Fatness was associated with blood pressures, HDL-C, tri-
glycerides, glucose, insulin, HOMA, hsCRP, ALT, AST:ALT,GGT,
leptin, and IL-6 after adjustment for age (model 1) and after
adjustment for age and fitness (model 2). Fitnesswasassociated
with blood pressures, HDL-C, triglycerides, glucose, insulin,
HOMA, hsCRP, ALT, AST:ALT, adiponectin, and leptin after
adjustment for age (model 1) and with HDL-C, triglycerides,
insulin, HOMA, and leptin after adjustment for age and fatness
(model 2). One hundred two participants completed 7-day food
diaries; and the relationships between fatness, fitness, and
cardiometabolic risk factors were not markedly changed after
adjustment for age, saturated fat intake, and total energy intake
(model 3, data not shown).
Systolic blood pressure was not significantly different in
men whowere slim and fit and those whowere slim and unfit
(114 ± 11 and 117 ± 13 mm Hg), but was higher in men who
were fat and fit and those whowere fat and unfit (130 ± 14 and
131 ± 14 mm Hg, P < .01 vs slim groups). Diastolic blood
pressure followed a similar pattern (Table S1, online supple-
ment). High-density lipoprotein cholesterol was not signifi-
cantly different in slim and fit, slim and unfit, and fat and fitand cardiometabolic risk factors in middle-aged white men,
Table 2 – Relationships between fatness, fitness, and cardiometabolic risk factors in regression models
Model 1 Model 2
Waist girth, cm VO2max, mL·kgFFM−1 ·min−1 Waist girth, cm VO2max, mL·kgFFM−1 ·min−1
SBP, mm Hg .56 ‡ −.25 † .55 ‡ −.03
DBP, mm Hg .53 ‡ −.19 ⁎ .55 ‡ .04
TC, mmol·L−1 .07 −.06 .06 −.04
HDL-C, mmol·L−1 −.32 ‡ .33 ‡ −.22 † .25 (.05) †
LDL-C, mmol·L−1 .10 −.12 .06 −.10
Triglycerides, mmol·L−1 .29 ‡ −.26 † .22 † −.17 (.02) ⁎
Glucose, mmol·L−1 .33 ‡ −.20 † .29 ‡ −.08
Insulin, μU·mL−1 .49 ‡ −.41 ‡ .39 ‡ −.26 (.05) ‡
HOMA .49 ‡ −.41 ‡ .38 ‡ −.26 (.06) ‡
hsCRP, mg·L−1 .44 ‡ −.22 † .42 ‡ −.05
ALT, U·L−1 .32 ‡ −.17 ⁎ .30 ‡ −.05
AST, U·L−1 .13 .02 .17 .08
AST:ALT −.35 ‡ .27 † −.29 † .15
GGT, U·L−1 .26 † −.09 .27 † .02
Fibrinogen, g·L−1 .10 −.14 .05 −.11
Adiponectin, ng·mL−1 −.36 ‡ .22 † −.33 ‡ .09
Leptin, ng·mL−1 .67 ‡ −.44 ‡ .57 ‡ −.22 (.04) †
TNF-α, pg·mL−1 −.06 −.05 −.10 −.09
IL-6, pg·mL−1 .19 ⁎ −.04 .21 ⁎ .05
Values are standardized β coefficients. Model 1 contained age and waist girth or age and VO2max. Model 2 contained age, waist girth, and
VO2max. ΔR2 is shown in parentheses in model 2 if the addition of VO2max made a significant contribution to the change in the amount of
variance that could be explained, P < .05. Triglycerides, hsCRP, ALT, and leptin were log transformed. Number of observations is 171, except SBP,
DBP, and glucose (183); HOMA (169); fibrinogen (151); adiponectin (182); leptin (174); and TNF-α and IL-6 (181). TC indicates total cholesterol.
⁎ P < .05.
† P < .01.
‡ P < .001.
4 M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L X X ( 2 0 1 1 ) X X X – X X Xgroups, but was lower in men who were fat and unfit
(Fig. 1). Triglyceride concentration was not significantly
different in slim and fit, slim and unfit, and fat and fit
groups, but was higher in men who were fat and unfit
(Fig. 1). Homeostasis model assessment of insulin resistance
was not significantly different in slim and fit and slim and
unfit groups, higher in the fat and fit group, and higher still in
the fat and unfit group (Fig. 1, with glucose and insulin
concentrations in Table S1 in the online supplement). High-
sensitivity C-reactive protein was not significantly different in
men whowere slim and fit and those who were slim and unfit
(0.93 ± 1.12 and 1.06 ± 0.93 mg·L−1), but was higher in menwho
were fat and fit and those who were fat and unfit (2.61 ± 2.75
and 2.00 ± 1.12 mg·L−1, P < .05 vs slim groups). Alanine
aminotransferase was not significantly different in slim and
fit and slim and unfit groups, higher in the fat and fit group,
and higher still in the fat and unfit group (Fig. 1). Aspartate
aminotransferase was not significantly different in groups of
different fatness and fitness, but the ratio of AST to ALT was
lower in the fat and fit group and lower still in the fat and unfit
group (Table S1, online supplement). γ-Glutamyltransferase
was not significantly different in men who were slim and fit
and those who were slim and unfit (23.69 ± 12.56 and 23.24 ±
8.12 U·L−1), but tended to be higher inmenwhowere fat and fit
and those who were fat and unfit (38.32 ± 33.30 and 40.68 ±
22.71 U·L−1, P ≤ .09 vs slim groups). Adiponectin was not
significantly different in slim groups, but was lower in fat
groups (Fig. 1). Leptin was not significantly different in slim
groups, but was higher in fat groups (Fig. 1). Total cholesterol,
LDL-C, fibrinogen, TNF-α, and IL-6 concentrations were notPlease cite this article as: O'Donovan G, et al, Fatness, fitness, a
Metabolism (2011), doi:10.1016/j.metabol.2011.06.009significantly different in groups of different fatness and
fitness (Table S1, online supplement).4. Discussion
Fatness and fitness were independently related to several
cardiometabolic risk factors in the present study, and some
traditional and novel risk factors were significantly different
in groups of different fatness and fitness. Differences in HDL-C
concentration, triglyceride concentration, ALT activity, and
HOMAmay explain why the risks of chronic disease are lower
in men who are fat and fit than those who are fat and unfit.
Our study of men who were fat, fit, and active is in keeping
with the notion that physical activity and the pursuit of
physical fitness reduce the risks associated with obesity [30].
This study was robust because we reduced the confound-
ing effects of biological and analytical variation and we
carefully identified men who were fat, fit, and active to
avoid misclassification. The within-subject variation in total
cholesterol (6%), HDL-C (7%), triglycerides (21%), and other
blood-borne risk factors is considerable [14]; and we took
blood on 2 occasions to obtain a better indication of
participants' average levels. Blood samples were stored at
−80°C and tested in the same analyzer run to minimize
analytical variation. A waist girth of greater than or equal to
100 cm was used to define fat men because it is associated
with the accumulation of visceral adipose tissue [31], and a
waist girth of less than or equal to 90 cm was used to define
slim men to avoid misclassification. Maximal oxygennd cardiometabolic risk factors in middle-aged white men,
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Fig. 1 – High-density lipoprotein cholesterol concentration (A), triglyceride concentration (B), HOMA (C), and ALT activity (D) in
58menwhowere slim and fit, 23 whowere slim and unfit, 38 whowere fat and fit, and 17 whowere fat and unfit. Adiponectin
concentration in 61 men who were slim and fit, 24 who were slim and unfit, 39 who were fat and fit, and 19 who were fat and
unfit (E). Leptin concentration in 54menwhowere slim and fit, 23whowere slim and unfit, 39whowere fat and fit, and 19who
were fat and unfit (F). Bars aremeans, and error bars are standard deviations. *P < .05, **P < .01, ***P < .001 vs slim and fit. †P < .05,
††P < .01, †††P < .001 vs slim and unfit. ‡P < .05, ‡‡P < .01, §P = .06 vs fat and fit.
5M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L X X ( 2 0 1 1 ) X X X – X X Xconsumption is the criterion measure of aerobic fitness, and
“fit” and “unfit”menwere definedwith reference to untrained
men of the same age [20]. The norms were largely derived
from cycling tests, and VO2maxwas expressed independent of
body weight to avoid penalizing heavier individuals. For
example, a 110-kg man of 40 years of age has an excellent
score of 4.0 L·min−1 when VO2max is expressed independent
of body weight and a below average score of 36 mL·kg−1·min−1
when VO2max is expressed relative to body weight [20]. Blair
and colleagues have concluded that a physically active
lifestyle can increase aerobic fitness and reduce all-cause
mortality, with [32] and without [3,33] assessing habitual
activity. It might be appropriate to assume that aerobic fitness
is a reflection of habitual activity in large studies because
“naturally fit” men are rare [15] and misclassification is
unlikely to bias toward the null. Any misclassification is
more likely to bias toward the null in small studies. Therefore,Please cite this article as: O'Donovan G, et al, Fatness, fitness,
Metabolism (2011), doi:10.1016/j.metabol.2011.06.009we only included active men in the slim and fit group and the
fat and fit group.
This study has a number of limitations. The selection of
waist girth thresholds was somewhat arbitrary; however, the
results were similar when the International Diabetes Feder-
ation [34] threshold of greater than or equal to 94 cmwas used
to identify fat men (Table S3, online supplement). There were
more men in each group when the single threshold was used,
and the similar results may reflect the conflicting forces of
greater sample size (which tends to increase power) and
greatermisclassification (which tends to bias toward the null).
The use of submaximal fitness tests might introduce bias
because they tend to overestimate VO2max. However, extrap-
olation only produced unrealistic values in 6 inactive men;
and one was allocated to the slim and unfit group, and 5 were
allocated to the fat and unfit group. Physical activity was self-
reported, but vigorous-intensity activity is recalled with someand cardiometabolic risk factors in middle-aged white men,
6 M E T A B O L I S M C L I N I C A L A N D E X P E R I M E N T A L X X ( 2 0 1 1 ) X X X – X X Xaccuracy [21]. Eighty-one (44%) of 183 participants did not
complete food diaries, but saturated fat intake and total
energy intake explained little of the variance in cardiometa-
bolic risk factors. Sample size was sufficient to detect several
statistically significant results; but a larger study might reveal
more about the relationships between fatness, fitness, fibrin-
ogen, IL-6, IL-10, TNF-α, and AST; however, it is noteworthy
that IL-10 was often undetectable in the present study and
other studies of healthymen [35,36]. The results of the present
study may not be observed when other measures of fatness
and fitness are used andmay not be generalizable to groups of
substantially different fatness, fitness, and activity. Our study
of white men cannot help explain why fitness may reduce the
risks of chronic disease in overweight and obese women [30].
It is interesting that we did not find significant differences
in the primary outcome variable, despite sufficient statistical
power. Significant differences in LDL-C have been observed in
other cross-sectional studies [26,37]; but we found no re-
lationships between fatness, fitness, and LDL-C in 113 men in
a previous study [26] or 171men in the present study. Exercise
interventions rarely bring about reductions in LDL-C [37];
however, exercise training can increase lipoprotein lipase
activity and, thus, improve HDL-C and triglyceride concentra-
tions [37-39]. Fatness (waist girth, centimeters) and fitness
(VO2max, milliliters per kilogram FFM per minute) were
independently related to HDL-C and triglycerides in the
present study, and the available evidence suggests that
exercise training may improve HDL-C and triglyceride con-
centrations with or without weight loss [40-42]. The reported
changes in HDL-C were modest, but the quality of most
interventions was poor.
It is increasingly apparent that insulin resistance is central
to cardiovascular disease and type 2 diabetes mellitus [6]. The
effect of exercise on insulin sensitivity is also well documen-
ted [43], and it is plausible that men who are fat and fit have a
greater capacity than men who are fat and unfit to store
excess fat in insulin-sensitive adipose tissue rather than the
viscera or the liver. Indeed, fatness (waist girth, centimeters)
and fitness (VO2max, milliliters per kilogram FFM per minute)
were independently associated with insulin resistance
(HOMA) in the present study; and we have previously reported
that visceral fat and liver fat were lower in men who were fat
and fit than those who were fat and unfit [44]. Visceral fat is
associated with dyslipidemia [9], and it is noteworthy that
HDL-C and triglycerides were significantly different in men
who were fat and fit and those who were fat and unfit.
Steatosis is associated with nonalcoholic fatty liver disease
[10], and it is also noteworthy that ALT and AST:ALT were
significantly different in men who were fat and fit and those
who were fat and unfit. Insulin resistance and hyperinsuline-
mia are associated with endothelial dysfunction [6], and
insulin concentrations may have been sufficient to impair
endothelial function and raise blood pressure in men who
were fat and fit and those who were fat and unfit. Obesity per
se may also raise blood pressure [45], and BMI and waist girth
were correlated with SBP and DBP independent of insulin
concentration (eg, the partial correlation between waist girth
and SBP was 0.5, P < .001).
Fitness is often associated with adipokines and markers of
inflammation independent of fatness [13]. Adiponectin in-Please cite this article as: O'Donovan G, et al, Fatness, fitness, a
Metabolism (2011), doi:10.1016/j.metabol.2011.06.009creases insulin sensitivity and has anti-inflammatory prop-
erties [6,7], but fitness was not associated with adiponectin
after adjustment for waist girth. Fitness also explained little of
the variance in proinflammatory cytokines; and we found no
significant differences in hsCRP, leptin, TNF-α, and IL-6 inmen
who were fat and fit and those who were fat and unfit. Age is
associated with inflammation, and participants in the present
study were relatively young and had relatively low concen-
trations of proinflammatory cytokines [46,47]: 3% of men who
were slim and fit, 26% of men who were slim and unfit, 50% of
men who were fat and fit, and 41% of men who were fat and
unfit had an elevated CRP concentration of greater than or
equal to 2.00 mg·L−1. The prevalence of elevated CRP in
overweight (BMI 25.0-29.9 kg·m2) and obese (BMI ≥30 kg·m2)
men decreased across low-, moderate-, and high-fitness
groups in a study of 722 men aged around 50 ± 10 years [47].
The prevalence of elevated fibrinogen (>2.97 g·L−1) in over-
weight and obese men also decreased across fitness tertiles
[48]. Obesity is associated with leptin resistance [7,49], which
may explain why leptin concentrations were similar in men
who were fat and fit and men who were fat and unfit.
The “fitness vs fatness” issue has provoked heated debate
in recent years [50], partly because fitness is more influential
than activity in reducing the morbidity and mortality
associated with obesity [30]. This discrepancy may occur
because objectively measured fitness is a better reflection of
habitual activity than self-reported activity [51]. This dis-
crepancy may also occur because fitness reflects time spent
in vigorous-intensity activity [52], which is probably more
beneficial to health than moderate-intensity activity [53,54].
The present study of cardiometabolic risk factors suggests
that fitness reduces the risks associated with obesity;
however, it is possible that fitness reduces all-cause
mortality independent of cardiometabolic risk factors [33].
More experimental research is required to determine the
independent effects of exercise training on cardiometabolic
risk factors in obese adults.
Supplementary materials related to this article can be
found online at doi:10.1016/j.metabol.2011.06.009.Funding
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